Skip to main content
Have a personal or library account? Click to login
Chronic low back pain and sleep disorders in older adults: a cross-sectional study Cover

Chronic low back pain and sleep disorders in older adults: a cross-sectional study

Open Access
|Mar 2026

Figures & Tables

Figure 1.

Flowchart of the inclusion process

Table 1.

Demographic characteristics of the sample

Characteristics(n = 100)
Age (years)69.8 ± 6.6
Female sex69 (69)
BMI27.3 ± 5.2
Marital status
Single22 (22)
Married45 (45)
Divorced18 (45)
Widower15 (15)
Education level
Illiterate2 (2)
Primary school43 (43)
Secondary school40 (40)
University degree15 (15)
Occupational status
Paid activity21 (21)
No paid activity79 (79)
CLBP duration (weeks)
12–236 (6)
24–355 (5)
36–526 (6)
>5283 (83)
Practice of physical activity
Yes39 (39)
No61 (61)
Medications in use (number)3.7 ± 2.5
Use of sleep-inducing medications31 (31)
Total hours of sleep (per night)6.2 ± 1.6
Pain intensity (0–10 points)7.6 ± 1.8
Functional disability (0–24 points)13.3 ± 5.3
OSA risk
No risk12 (12)
Low risk50 (50)
High risk36 (36)
Excessive daytime sleepiness (0–24 points)7.3 ± 5.0
Sleep quality (0–21 points)8.54 ± 4.0
Depression symptoms (0–15 points)4.9 ± 4.1
Comorbidities (total)5.5 ± 2.3

[i] BMI - body mass index, CLBP - chronic low back pain, OSA - obstructive sleep apnoea.

[ii] Data expressed by mean ± standard deviation or frequency (percentage).

Table 2.

Results of univariate linear regressions and multivariable linear regressions between the risk of OSA (independent variable) and pain intensity and functional disability (dependent variables)

Pain intensity (NPRS)Functional disability (Roland–Morris Disability Questionnaire)
Independent variables: OSA risk (Berlin Questionnaire); dependent variables: pain intensity (NPRS) and functional disability (Roland–Morris Disability Questionnaire); covariates: age, depressive symptoms (GDS-15), BMI, occupational status, comorbidities number.
R2 (adjusted R2), %Coefficient β (CI 95%)p valueR2 (adjusted R2), %Coefficient β (CI 95%)p value
Univariate linear regression modelUnivariate linear regression model
(constant)9.1 (8.1)6.72 (6.00–7.43)0.00(constant)10.7 (9.8)10.19 (8.12–12.26)0.00
OSA risk (Berlin Questionnaire)0.30 (0.16–0.72)0.00aOSA risk (Berlin Questionnaire)0.33 (0.20–0.75)0.00a
Multivariable linear regression modelMultivariable linear regression model
(constant)16.5 (11.1)2.72 (−1.98 to 7.42)0.25(constant)47.2 (43.8)0.13 (−10.86 to 11.12)0.98
Age0.09 (−0.10 to 0.28)0.36Age−0.02 (−0.17 to 0.14)0.83
Depressive symptoms (GDS-15)0.19 (−0.01 to 0.40)0.06Depressive symptoms (GDS-15)0.52 (0.35–0.67)0.00a
BMI0.13 (−0.08 to 0.33)0.22BMI0.25 (0.09–0.41)0.00a
Occupational status0.12 (−0.07 to 0.31)0.20Occupational status0.07 (−0.08 to 0.22)0.38
Comorbidities number0.07 (−0.14 to 0.28)0.53Comorbidities number0.16 (−0.01 to 0.33)0.06
OAS risk (Berlin Questionnaire)0.19 (−0.03 to 0.59)0.07OSA risk (Berlin Questionnaire)0.05 (−0.17 to 0.32)0.53

BMI - body mass index, GDS-15 - geriatric depression scale, NPRS - numerical pain rating scale, OSA - obstructive sleep apnoea.

Effect size (β): 0.10–0.29 = small; 0.30–0.49 = moderate; ≥ 0.50 = strong.

a - Statistically significant.

Table 3.

Results of univariate linear regressions and multivariable linear regressions between excessive daytime sleepiness (independent variable) and pain intensity and functional disability (dependent variables)

Pain intensity (NPRS)Functional disability (Roland–Morris Disability Questionnaire)
Independent variables: excessive daytime sleepiness; dependent variables: pain intensity (NPRS) and functional disability (Roland–Morris Disability Questionnaire); covariates: age, depressive symptoms (GDS-15), BMI, occupational status, comorbidities number.
R2 (adjusted R2), %Coefficient β (CI 95%)p valueR2 (adjusted R2), %Coefficient β (CI 95%)p value
Univariate linear regression modelUnivariate linear regression model
(constant)0.00 (−0.01)7.72 (7.01–8.37)0.00(constant)11.3 (10.4)10.60 (8.82–12.44)0.00
Excessive daytime sleepiness (Epworth sleepiness scale)−0.02 (−0.22 to 0.18)0.84Excessive daytime sleepiness (Epworth sleepiness scale)0.34 (0.15−0.53)0.00a
Multivariable linear regression modelMultivariable linear regression model
(constant)18.2 (12.8)1.61 (−3.09 to 6.32)0.50(constant)48.4 (45.0)0.40 (−10.65 to 11.45)0.94
Age0.12 (−0.07 to 0.31)0.22Age−0.02 (−0.17 to 0.14)0.83
Depressive symptoms (GDS-15)0.28 (0.07–0.47)0.01aDepressive symptoms (GDS-15)0.52 (0.36–0.68)0.00a
BMI0.23 (0.03–0.43)0.02BMI0.24 (0.08–0.40)0.00a
Occupational status0.15 (−0.04 to 0.34)0.12Occupational status0.06 (−0.09 to 0.21)0.44
Comorbidities number0.16 (−0.05 to 0.37)0.14Comorbidities number0.14 (−0.02 to 0.31)0.09
Excessive daytime sleepiness (Epworth sleepiness scale)−0.21 (−0.42 to −0.01)0.04Excessive daytime sleepiness (Epworth sleepiness scale)0.10 (−0.06 to 0.27)0.23

BMI - body mass index, GDS-15 - geriatric depression scale, NPRS - numerical pain rating scale.

Effect size (β): 0.10–0.29 = small; 0.30–0.49 = moderate; ≥0.50 = strong.

a - Statistically significant.

Table 4.

Results of univariate linear regressions and multivariable linear regressions between sleep quality (independent variable) and pain intensity and functional disability (dependent variables)

Pain intensity (NPRS)Functional disability (Roland–Morris Disability Questionnaire)
Independent variables: Sleep Quality (PSQI); dependent variables: pain intensity (NPRS) and functional disability (Roland–Morris Disability Questionnaire);
covariates: age, depressive symptoms (GDS-15), BMI, occupational status, comorbidities number.
R2 (Adjusted R2), %Coefficient β (CI 95%)p valueR2 (Adjusted R2), %Coefficient β (CI 95%)p value
Univariate linear regression modelUnivariate linear regression model
(constant)8.0 (7.0)6.59 (5.76–7.41)0.00(constant)28.8 (28.1)7.14 (4.99–9.28)0.00
Sleep quality (PSQI)0.28 (0.09–0.47)0.00aSleep quality (PSQI)0.54 (0.37–0.71)0.00a
Multivariable linear regression modelMultivariable linear regression model
(constant)15.5 (10.0)2.21 (−2.55 to 6.97)0.36(constant)51.0 (47.8)−1.65 (−12.30 to 9.00)0.76
Age0.09 (−0.10 to 0.29)0.34Age−0.01 (−0.16 to 0.14)0.88
Depressive symptoms (GDS-15)0.15 (−0.08 to 0.38)0.20Depressive symptoms0.41 (0.23–0.58)0.00a
BMI0.16 (−0.04 to 0.36)0.12BMI0.24 (0.08 to 0.39)0.00a
Occupational status0.14 (−0.05 to 0.34)0.15Occupational status0.10 (−0.04 to 0.25)0.16
Comorbidities number0.09 (−0.12 to 0.30)0.41Comorbidities number0.14 (−0.02 to 0.30)0.09
Sleep quality (PSQI)0.17 (−0.06 to 0.41)0.15Sleep quality (PSQI)0.25 (0.07–0.43)0.01a

BMI - body mass index, GDS-15 - geriatric depression scale, NPRS - numerical pain rating scale, PSQI - Pittsburgh sleep quality index.

Effect size (β): 0.10–0.29 = small; 0.30–0.49 = moderate; ≥0.50 = strong.

a - Statistically significant.

Table 5.

Prevalence of sleep complaints (n = 100)

Sleep complaints‘Do you have any of the following problems during sleep?’, n (%)‘How frequent is the problem?’, n (%)
Less than once a monthOnce a month2–3 times a month1–2 times a week3 or more times a week
Any sleep complaint96 (96)a-----
Insufficient sleep55 (55)a4 (4)3 (3)3 (3)17 (17)28 (28)
Snoring57 (57)a5 (5)2 (2)5 (5)13 (13)32 (32)
Insomnia53 (53)4 (4)8 (8)5 (5)9 (9)27 (27)
Excessive daytime sleepiness31 (31)1 (1)3 (3)3 (3)10 (10)14 (14)
Nocturnal awakening76 (76)a6 (6)1 (1)3 (3)11 (11)55 (55)a
Breath complaints23 (23)4 (4)3 (3)4 (4)2 (2)10 (10)
Move a lot during sleep49 (49)1 (1)1 (1)0 (0)10 (7)37 (37)
Kick legs33 (33)3 (3)1 (1)0 (0)5 (5)24 (24)
Sleep-talking19 (19)4 (4)4 (4)3 (3)3 (3)5 (5)
Nightmare41 (41)9 (9)12 (12)6 (6)11 (11)3 (3)
Bruxism31 (31)3 (3)8 (8)4 (4)1 (1)15 (15)
Sleepwalking0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)
Other complaints5 (5)-----

a - Most prevalent.

Language: English
Page range: 87 - 103
Submitted on: Jul 16, 2025
Accepted on: Nov 4, 2025
Published on: Mar 31, 2026
Published by: University of Physical Education in Warsaw
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Gabriel Mendes et al., published by Józef Piłsudski University of Physical Education in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.